Satalkar Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2019.
2019 Aurangabad, Maharashtra, India Active
Last Updated:
About Satalkar Pharmaceutical Private Limited

Satalkar Pharmaceutical Private Limited, a active private limited company, was established on 15 January 2019 in Aurangabad, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100MH2019PTC319619. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Urmila Dnyaneshwar Satalkar (Director), Dnyaneshwar Haribhau Satalkar (Director). It is based at H No-12, S No-15, Jadhavwadi,, Aurangabad, Maharashtra, 431001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2019PTC319619

  • Registration Number

    319619

  • Incorporation Date

    15 January 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 27 Days
Company report

Satalkar Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Satalkar Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Satalkar Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Urmila Dnyaneshwar Satalkar Director 15 Jan 2019 Current
Dnyaneshwar Haribhau Satalkar Director 15 Jan 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Satalkar Pharmaceutical.

Enhance accessibility to Satalkar Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Satalkar Pharmaceutical revenue growth over time
Satalkar Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Satalkar Pharmaceutical?

Unlock access to Satalkar Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Satalkar Pharmaceutical?

Unlock and access historical data on people associated with Satalkar Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Satalkar Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satalkar Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Satalkar Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Urmila Dnyaneshwar Satalkar was appointed as a Director was appointed as a Director on 15 Jan 2019 & has been associated with this company since 7 years 27 days . was recorded as a recent event.

  • Director Appointment

    Dnyaneshwar Haribhau Satalkar was appointed as a Director was appointed as a Director on 15 Jan 2019 & has been associated with this company since 7 years 27 days . was recorded as a recent event.

  • Company Incorporation

    Satalkar Pharmaceutical Private Limited was registered on 15 Jan 2019 with Roc Mumbai & aged 7 years 27 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Satalkar Pharmaceutical Private Limited?

The CIN of Satalkar Pharmaceutical Private Limited is U24100MH2019PTC319619.

Where is Satalkar Pharmaceutical Private Limited headquartered?

Satalkar Pharmaceutical Private Limited is headquartered at H No-12, S No-15, Jadhavwadi,, Aurangabad, Maharashtra, 431001.

When was Satalkar Pharmaceutical Private Limited incorporated?

Satalkar Pharmaceutical Private Limited was incorporated on 15 January 2019.

Who are the current directors of Satalkar Pharmaceutical Private Limited?

The current directors of Satalkar Pharmaceutical Private Limited are

What is the primary industry of Satalkar Pharmaceutical Private Limited?

The primary industry of Satalkar Pharmaceutical Private Limited is Pharma.

Is Satalkar Pharmaceutical Private Limited a listed company?

Satalkar Pharmaceutical Private Limited is unlisted.

What is the capital structure of Satalkar Pharmaceutical Private Limited?

The authorized capital of Satalkar Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Satalkar Pharmaceutical Private Limited?

The compliance status of Satalkar Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available